vs
COMPX INTERNATIONAL INC（CIX）与Ginkgo Bioworks Holdings, Inc.（DNA）财务数据对比。点击上方公司名可切换其他公司
COMPX INTERNATIONAL INC的季度营收约是Ginkgo Bioworks Holdings, Inc.的1.1倍（$37.7M vs $33.4M），COMPX INTERNATIONAL INC同比增速更快（-1.9% vs -23.8%），COMPX INTERNATIONAL INC自由现金流更多（$11.4M vs $-47.7M），过去两年COMPX INTERNATIONAL INC的营收复合增速更高（-0.4% vs -6.2%）
COMPX国际是一家多元化安全与控制产品制造商，主营高性能锁具系统、电子门禁解决方案、人体工学工作站部件及船用五金，核心市场覆盖北美、欧洲，服务商业、住宅、工业、医疗、休闲船舶等领域客户。
Ginkgo Bioworks Holdings, Inc.是一家2008年由五名麻省理工学院科学家创立的美国生物技术企业，由杰森·凯利掌舵。公司专注于基因工程改造，为其他生物科技企业开发具备工业应用价值的菌株，帮助合作方省去合成生物学设计初期的重复研发成本，号称「生物制造平台企业」，2019年估值就已达42亿美元。
CIX vs DNA — 直观对比
营收规模更大
CIX
是对方的1.1倍
$33.4M
营收增速更快
CIX
高出22.0%
-23.8%
自由现金流更多
CIX
多$59.1M
$-47.7M
两年增速更快
CIX
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.7M | $33.4M |
| 净利润 | $4.7M | — |
| 毛利率 | 32.1% | — |
| 营业利润率 | 15.0% | -211.9% |
| 净利率 | 12.4% | — |
| 营收同比 | -1.9% | -23.8% |
| 净利润同比 | 3.6% | — |
| 每股收益（稀释后） | $0.38 | $-1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIXDNA
| Q4 25 | $37.7M | $33.4M | ||
| Q3 25 | $40.0M | $38.8M | ||
| Q2 25 | $40.4M | $49.6M | ||
| Q1 25 | $40.3M | $48.3M | ||
| Q4 24 | $38.4M | $43.8M | ||
| Q3 24 | $33.7M | $89.0M | ||
| Q2 24 | $35.9M | $56.2M | ||
| Q1 24 | $38.0M | $37.9M |
净利润CIXDNA
| Q4 25 | $4.7M | — | ||
| Q3 25 | $4.2M | $-80.8M | ||
| Q2 25 | $5.5M | $-60.3M | ||
| Q1 25 | $5.1M | $-91.0M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $3.5M | $-56.4M | ||
| Q2 24 | $4.8M | $-217.2M | ||
| Q1 24 | $3.8M | $-165.9M |
毛利率CIXDNA
| Q4 25 | 32.1% | — | ||
| Q3 25 | 27.6% | — | ||
| Q2 25 | 31.9% | — | ||
| Q1 25 | 30.2% | — | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 28.1% | — | ||
| Q2 24 | 31.1% | — | ||
| Q1 24 | 25.5% | — |
营业利润率CIXDNA
| Q4 25 | 15.0% | -211.9% | ||
| Q3 25 | 11.9% | -231.8% | ||
| Q2 25 | 15.7% | -132.1% | ||
| Q1 25 | 14.6% | -184.1% | ||
| Q4 24 | 12.7% | -236.3% | ||
| Q3 24 | 9.9% | -62.0% | ||
| Q2 24 | 14.2% | -396.7% | ||
| Q1 24 | 9.8% | -469.1% |
净利率CIXDNA
| Q4 25 | 12.4% | — | ||
| Q3 25 | 10.6% | -207.9% | ||
| Q2 25 | 13.5% | -121.6% | ||
| Q1 25 | 12.7% | -188.2% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 10.3% | -63.3% | ||
| Q2 24 | 13.5% | -386.4% | ||
| Q1 24 | 9.9% | -437.3% |
每股收益（稀释后）CIXDNA
| Q4 25 | $0.38 | $-1.41 | ||
| Q3 25 | $0.34 | $-1.45 | ||
| Q2 25 | $0.44 | $-1.10 | ||
| Q1 25 | $0.42 | $-1.68 | ||
| Q4 24 | $0.37 | $-1.91 | ||
| Q3 24 | $0.28 | $-1.08 | ||
| Q2 24 | $0.39 | $-4.23 | ||
| Q1 24 | $0.31 | $-3.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.1M | $422.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $138.6M | $508.6M |
| 总资产 | $156.2M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CIXDNA
| Q4 25 | $54.1M | $422.6M | ||
| Q3 25 | $46.3M | $495.5M | ||
| Q2 25 | $56.2M | $559.4M | ||
| Q1 25 | $56.1M | $325.3M | ||
| Q4 24 | $60.8M | $561.6M | ||
| Q3 24 | $58.8M | $616.2M | ||
| Q2 24 | $82.1M | $730.4M | ||
| Q1 24 | $75.6M | $840.4M |
股东权益CIXDNA
| Q4 25 | $138.6M | $508.6M | ||
| Q3 25 | $137.7M | $559.8M | ||
| Q2 25 | $149.5M | $613.0M | ||
| Q1 25 | $147.6M | $647.4M | ||
| Q4 24 | $146.1M | $716.1M | ||
| Q3 24 | $145.3M | $797.9M | ||
| Q2 24 | $170.2M | $833.1M | ||
| Q1 24 | $168.9M | $987.3M |
总资产CIXDNA
| Q4 25 | $156.2M | $1.1B | ||
| Q3 25 | $153.7M | $1.2B | ||
| Q2 25 | $164.8M | $1.2B | ||
| Q1 25 | $162.2M | $1.3B | ||
| Q4 24 | $163.0M | $1.4B | ||
| Q3 24 | $160.1M | $1.5B | ||
| Q2 24 | $185.1M | $1.6B | ||
| Q1 24 | $181.7M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.0M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | $11.4M | $-47.7M |
| 自由现金流率自由现金流/营收 | 30.3% | -142.8% |
| 资本支出强度资本支出/营收 | 1.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.57× | — |
| 过去12个月自由现金流最近4个季度 | $19.1M | — |
8季度趋势，按日历期对齐
经营现金流CIXDNA
| Q4 25 | $12.0M | $-47.7M | ||
| Q3 25 | $6.3M | $-31.6M | ||
| Q2 25 | $4.7M | $-40.3M | ||
| Q1 25 | $-137.0K | $-51.5M | ||
| Q4 24 | $7.3M | $-42.4M | ||
| Q3 24 | $4.1M | $-103.5M | ||
| Q2 24 | $9.8M | $-84.4M | ||
| Q1 24 | $1.7M | $-89.3M |
自由现金流CIXDNA
| Q4 25 | $11.4M | $-47.7M | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $3.4M | $-40.3M | ||
| Q1 25 | $-959.0K | $-59.1M | ||
| Q4 24 | $7.1M | $-56.1M | ||
| Q3 24 | $3.6M | $-118.6M | ||
| Q2 24 | $9.4M | $-111.4M | ||
| Q1 24 | $1.4M | $-96.0M |
自由现金流率CIXDNA
| Q4 25 | 30.3% | -142.8% | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 8.4% | -81.2% | ||
| Q1 25 | -2.4% | -122.4% | ||
| Q4 24 | 18.5% | -128.0% | ||
| Q3 24 | 10.8% | -133.2% | ||
| Q2 24 | 26.2% | -198.2% | ||
| Q1 24 | 3.6% | -252.9% |
资本支出强度CIXDNA
| Q4 25 | 1.6% | 0.0% | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 3.3% | 0.1% | ||
| Q1 25 | 2.0% | 15.8% | ||
| Q4 24 | 0.6% | 31.3% | ||
| Q3 24 | 1.4% | 16.9% | ||
| Q2 24 | 1.2% | 48.1% | ||
| Q1 24 | 0.8% | 17.7% |
现金转化率CIXDNA
| Q4 25 | 2.57× | — | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | -0.03× | — | ||
| Q4 24 | 1.62× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 2.03× | — | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CIX
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
DNA
| Cell Engineering Segment | $26.0M | 78% |
| Other | $7.4M | 22% |
